Event: SABCS 2023

0:17:14

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

0:01:08

Highlights of SABCS 2022 | 7th Jan 2023 | Dr. Manish Singhal

1:51:27

SABCS 2023: View from the Trenches - What to do Monday Morning

1:57:50

SABCS 2023: Toxicity Management - Next Gen Therapies Means Next Gen Toxicities

0:00:34

Highlights from SABCS 2023: recognition for breast cancer prevention

0:01:03

Highlights from SABCS 2023

1:02:56

SABCS 2023: Less is More poster spotlight

0:22:55

SABCS 2021: Approving new therapies for early breast cancer

1:04:17

SABCS 2023: Immunotherapy Purpose, Resistance, and Toxicity

0:01:24

Highlights from SABCS 2023: novel agents and insights on HER2 dynamics in breast cancer

0:01:57

SABCS 2023 highlights: PARSIFAL-LONG, MONARCH 3, KATHERINE

1:06:46

SABCS 2023: State of the Art - Targeting Mutant ER

1:45:47

SABCS 2024: Tumor heterogeneity and evolution

0:01:31

Highlights from SABCS 2023: the future of immunotherapy in higher-risk ER+ breast cancer

1:02:09

SABCS 2023: Translational Controversies

0:00:43

Anthracycline-based therapies and exercise interventions: insights from SABCS 2023

0:20:29

Highlights From the 45th San Antonio Breast Cancer Symposium

0:00:50

Update on Keynote 522, the current standard of care for triple negative breast cancer.

1:00:11

Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight on the Latest in MBC

0:00:32

Highlights in HER2-low breast cancer at SABCS 2022

0:00:55

Can we forego axillary lymph node dissection in early breast cancer?

0:00:54

NSABP B-51: Can we forego radiation in early breast cancer? | #cancer #oncology

0:56:58

Breast Cancer Seminar Series: December 2023 - SABCS Highlights

0:01:16

Key data at SABCS 2022